ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Swelling During Dialysis (BRASE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01396863
Recruitment Status : Completed
First Posted : July 19, 2011
Last Update Posted : March 22, 2012
Sponsor:
Collaborator:
The Danish Medical Research Council
Information provided by (Responsible Party):
University of Aarhus

Brief Summary:

The proposed controlled, randomized study aims to compare pre-dilution hemodiafiltration (HDF) and low flux hemodialysis (HD) regarding acute changes in the brain.

The study consist of two examination days placed one week apart. 12 HD patients will be recruited to the study. The patients will be randomly placed in two groups: Pre-dilution hemodiafiltration during the first examination and low flux hemodialysis during the second day or vice versa.

Brain Magnetic Resonance Imaging (MRI) will be obtained before and after both treatments. The MRI-data will later be processed to estimate brain volume changes during the two types of treatment.


Condition or disease Intervention/treatment Phase
End Stage Renal Disease Procedure: HDF during the first examination Procedure: HD during the first examination Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Acute Brain Volume Changes in Haemodialysis: Comparison of Low Flux Haemodialysis With Pre-dilution Haemodiafiltration
Study Start Date : July 2011
Actual Primary Completion Date : February 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis

Arm Intervention/treatment
Active Comparator: First treatment HDF
The patient will receive treatment with pre-dilution hemodiafiltration during the first examination day. During the second examination day the patient will receive treatment with low flux hemodialysis.
Procedure: HDF during the first examination

The patient will receive treatment with pre-dilution hemodiafiltration during the first examination.

During the second examination the patient will receive treatment with low flux hemodialysis.

MRI of the brain will be performed before and after the treatment. The MRI-data will later be processed to determine the degree of brain volume change due to the treatment.


Active Comparator: First treatment HD
The patient will receive treatment with low flux hemodialysis during the first examination day. During the second examination day the patient will receive treatment with pre-dilution hemodiafiltration.
Procedure: HD during the first examination

The patient will receive treatment with low flux hemodialysis during the first examination.

During the second examination the patient will receive treatment with pre-dilution hemodiafiltration.

MRI of the brain will be performed before and after the treatment. The MRI-data will later be processed to determine the degree of brain volume change due to the treatment.





Primary Outcome Measures :
  1. Percent Brain Volume Change (PBVC) [ Time Frame: Brain volume before and after one hemodialysis session (4,5 hours) and one session of hemodiafiltration (4,5 hours). Dialysis sessions are performed one week apart. ]

    Brain volume before and after one hemodialysis session (4,5 hours) and one session of hemodiafiltration (4,5 hours). Dialysis sessions are performed one week apart. Randomization determines the order of treatment (hemodialysis vs hemodiafiltration).

    MRI-data will later be processed to estimate the PBVC.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age ≥ 18 years
  • Informed consent
  • Patient with end-stage renal disease (ESRD)
  • Stabile hemodialysis treatment (Kt/V ≥ 1.3)
  • No contraindications against MRI (pacemaker or other metal implants, claustrophobia, severe adiposity)
  • Weight <140kg

Exclusion Criteria:

  • Clinical signs of new structural, thromboembolic or vascular brain disease the last 3 month before entering the study
  • Changes in corticosteroid treatment during the last two weeks
  • Change in diuretics during the last two weeks
  • Non-compliant with regard to salt and fluid intake
  • Acute disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01396863


Locations
Denmark
Department of Renal Medicine C, Aarhus University Hospital, Skejby
Aarhus N, Denmark, 8200
The MR-Research Centre, Aarhus University Hospital, Skejby
Aarhus N, Denmark, 8200
Sponsors and Collaborators
University of Aarhus
The Danish Medical Research Council
Investigators
Study Director: Jens D. Jensen, MD, PhD Department of Renal Medicine C, Aarhus University Hospital, Skejby, Denmark
Principal Investigator: Niels Johansen, BSc Medicine Department of Renal Medicine C, Aarhus University Hospital, Skejby, Denmark

Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT01396863     History of Changes
Other Study ID Numbers: VEK20100228
First Posted: July 19, 2011    Key Record Dates
Last Update Posted: March 22, 2012
Last Verified: March 2012

Keywords provided by University of Aarhus:
Renal dialysis
Hemodiafiltration
Hemodialysis
MRI

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases